Space-Eyes Goes Public. The Real Question Is Whether It Can Win.

☰

Market Snapshot

Defense-tech is not a theme right now. It is a budget line item.

The Pentagon’s fiscal 2027 budget request, released in April 2026, allocates more than $70 billion for military drones and counter-drone weapon systems combined — the largest such investment in U.S. history. The Defense Autonomous Warfare Group alone is requesting $54.6 billion in FY2027, up from $225.9 million in FY2026. That is not a rounding error. That is a 243-fold increase in a single budget cycle. The Army separately carved out $994 million specifically for small counter-UAS procurement, nearly double its enacted FY2026 figure.

The market backdrop for defense software companies is as favorable as it has been in a generation. Palantir reported Q1 2026 total revenue of $1.63 billion, up 85% year over year, with U.S. government revenue growing 84% to $687 million. Anduril secured a 10-year Army enterprise contract with a ceiling of up to $20 billion in March 2026. Defense-related venture funding topped $4.5 billion in Q1 2026 alone, a record quarter.

It is into this environment that Space-Eyes, a 35-person Miami geospatial intelligence firm, has chosen to go public.

The mechanism is a SPAC merger with McKinley Acquisition Corp. (Nasdaq: MKLY). MKLY shares have traded in a tight range near $10.00 since its August 2025 IPO, consistent with typical pre-merger SPAC behavior. The deal was announced July 31, 2026. The combined company would list on Nasdaq under the ticker CUAS, pending exchange approval, with a close expected in Q4 2026.

That is the market context. The trading question is harder.

Why This Stock Is in Focus

Let’s be honest about what drove the headlines: Eric Trump. Reuters reported in late July 2026 that Trump has become the third-largest private investor in Space-Eyes and is expected to serve as a strategic adviser to the combined business following the transaction. That association has consumed most of the coverage.

Strip that away and the actual question for traders is this: can a company generating roughly $1 million in annual revenue — with historical contract awards typically ranging between $300,000 and $400,000 annually — justify a $638 million pro-forma equity valuation by converting pending contract negotiations into signed government awards?

The reason it is worth tracking: the cUAS market is one of the few genuine structural growth stories in defense right now, the budget numbers behind it are verified and substantial, and the merger timeline creates a defined catalyst window between now and Q4 close. Traders who understand what to watch have a cleaner framework than the noise suggests.

The Technical Picture

MKLY, as a pre-merger SPAC, has effectively been range-bound near its $10.00 trust value since its August 2025 IPO. The 52-week range has been approximately $9.85 to $10.09, with minimal volume and near-zero trend structure. This is normal for SPAC vehicles pre-announcement.

The merger announcement on July 31 is the first real catalyst this vehicle has seen. Post-announcement price action in SPAC deals typically follows one of two patterns: an initial pop on deal excitement followed by redemption-driven compression, or sustained accumulation if institutional interest in the PIPE is credible and contract momentum develops alongside the S-4 filing timeline.

Key levels to monitor:

• $10.00 trust floor: This is the redemption anchor. Shares should hold near this level as long as institutional redemptions remain moderate and the deal timeline stays intact.
• PIPE conversion progress: The $75 million Securities Purchase Agreement provides up to $70 million in additional senior secured convertible notes beyond the initial $5 million tranche. Watch SEC filings for S-4 registration and any early indication of PIPE investor participation beyond the minimum commitment.
• Volume expansion: MKLY averaged very thin volume pre-announcement. Any sustained volume expansion above the 30-day average would signal institutional positioning, not just retail reaction to the Trump headline.
• Post-announcement trading range: If shares hold above the trust NAV of $10.00 on above-average volume through the first several sessions post-announcement, that is a constructive technical signal. A failure back to NAV on heavy volume would suggest redemption pressure is building early.

There is no meaningful moving average or momentum structure to analyze yet on MKLY given its SPAC history. The technicals that matter here are deal mechanics, not chart patterns.

The Catalyst

The opportunity Space-Eyes is targeting is verifiably large. Army procurement for small counter-drone technology is budgeted at $994 million in FY2027, nearly doubling the prior year’s enacted funding. The Pentagon’s total FY2027 ask for drones and counter-drone systems combined exceeds $70 billion. Global government spending on counter-UAS systems surpassed $29 billion in publicly announced contracts in Q1 2026 alone.

Space-Eyes’ core product is a platform called CATE AI, a sensor-agnostic fusion engine integrating radar, RF, electro-optical, infrared, and satellite inputs into a single air picture. The sensor-agnostic design is the strategically important piece. Defense agencies are not replacing existing radar networks. A platform that layers over current hardware and improves it immediately compresses the procurement conversation significantly, at least in theory.

Slight tangent, but it matters: the Army’s March 2026 decision to award Anduril a 10-year enterprise contract with up to a $20 billion ceiling — with the first task order going straight to counter-UAS — signals how the Pentagon is structuring its largest cUAS relationships. Anduril’s Lattice platform is now the Army’s preferred tactical command-and-control standard. That progressively narrows the addressable market for vendors that are not integrated into that ecosystem. Space-Eyes needs to carve out a lane that does not require head-to-head competition with Lattice on the Army’s core programs.

Space-Eyes says it is currently negotiating contracts worth approximately $35 million over five years, a significant jump from its historical run rate. The company also holds SBIR Phase III status and opened a Washington office in January 2026. Those are real, if early, signals of government engagement. The company processes over two terabytes of data monthly from more than 75 sources. For a 35-person firm, that is a meaningfully dense data infrastructure.

The catalyst that will determine whether the investment thesis is real or aspirational is contract conversion. Not negotiation. Signed awards. Between announcement and Q4 shareholder vote, any government contract announcement transforms the revenue picture from theoretical to real and directly changes institutional redemption calculus.

Risk Assessment

There are four distinct risk layers here and traders should keep them separated.

Valuation risk: At roughly $1 million in current annual revenue, the $638 million pro-forma equity valuation represents approximately 638 times trailing revenue. Even granting every optimistic assumption about contract conversion, investors are buying a thesis, not a financial record. The implied enterprise value of $370 million is slightly more defensible if the $35 million in pending contracts begins to convert, but it still prices in execution that has not happened.

Redemption risk: SPAC structures have largely lost favor since the 2020 to 2022 boom period, as many companies that went public through these vehicles struggled to meet growth projections after listing. If McKinley shareholders redeem heavily before close, the capital available to Space-Eyes shrinks materially and the $638 million pro-forma equity figure no longer reflects actual capitalization. McKinley held $176.7 million in trust as of March 31, 2026. How much of that remains post-redemption is the variable most analysts underweight in early SPAC analysis.

Capital structure risk: The $75 million Securities Purchase Agreement includes senior secured convertible notes bearing a 10% annual interest rate maturing in 2031. At 10%, those notes are not cheap capital. They create dilution pressure and interest expense on a company with minimal current cash generation. PIPE investors also receive shares equal to 9.9% of McKinley’s outstanding common stock at subsequent closings, adding further dilution to the equation.

Political and regulatory risk: Eric Trump’s advisory and investor role creates a concentrated reputational and regulatory risk profile that can shift quickly with changes in political conditions. The association may have correlated with contract access during this administration. It can also attract oversight and scrutiny that a company at this stage of development is not equipped to navigate. Eric Trump’s representatives did not respond publicly to questions about conflict-of-interest measures. That silence is a material oversight risk, not a governance footnote.

Competitive risk: Anduril’s Lattice platform is now an established Army standard. DroneShield, D-Fend Solutions, Hidden Level, and Fortem Technologies are all competing in overlapping market segments with more established revenue bases. Space-Eyes is entering a crowded field at a late stage of the initial procurement wave, where one of the key challenges for smaller vendors is getting the procurement message across in a very crowded market.

Scenario Framework

Bull case: Space-Eyes announces one or more signed government contracts in the $5 to $15 million range between now and the Q4 shareholder vote. Redemptions on McKinley’s trust remain below 40%, leaving the combined entity with meaningful working capital. The S-4 registration moves swiftly through SEC review, PIPE investors fund subsequent tranches, and the 638x revenue multiple compresses toward something defensible as the revenue base expands. In this scenario, CUAS shares at listing would likely trade at a premium to NAV as institutional investors who passed on redemption are joined by defense-tech oriented funds seeking cUAS exposure without Anduril’s private market lock-up.

Base case: No major contract announcements before Q4 close. Moderate redemptions reduce available trust capital to somewhere between $80 million and $120 million. The company lists on Nasdaq under CUAS with a smaller public float than the pro-forma figures suggest, begins executing on its contract pipeline in 2027, and trades as a high-risk, early-stage defense software name with a volatile, news-driven price action. Valuation remains elevated relative to revenue but begins to compress as contract wins (or misses) accumulate over the following four to eight quarters.

Bear case: Heavy redemptions drain the trust, reducing available capital below $50 million. Pending contract negotiations do not convert into signed awards before or shortly after the shareholder vote. The convertible note dilution and 10% interest burden pressure the balance sheet. The company struggles to differentiate its sensor-agnostic platform against more established vendors in an increasingly competitive cUAS market. Shares trade at or below NAV post-listing, and the thesis resolves as another SPAC that could not bridge the gap between early-stage revenue and institutional-grade contract backlog.

Trader’s Checklist

Between now and Q4 close, three developments will tell traders whether the thesis is hardening or softening. Watch these in order of importance.

• Contract announcements: Any signed government award transforms the revenue picture from theoretical to real. A single meaningful contract announcement between now and the shareholder vote materially changes how institutional investors approach their redemption decisions. This is the single highest-priority signal to monitor.
• Redemption rate and S-4 filing timing: Watch for the registration statement filing date. Early indications of institutional interest in PIPE participation beyond the initial $5 million tranche will signal how much of the $638 million pro-forma figure holds. Heavy early redemption pressure visible in SEC filings is a direct warning sign.
• Competitive landscape developments: Any major new cUAS contract awarded to a direct competitor, particularly under IDIQ vehicles where Space-Eyes is not an eligible vendor, narrows the addressable market. Track DoD contract announcements in the cUAS category through the Q4 close window for context on where procurement dollars are actually flowing.

The macro tailwind is real. The Pentagon is spending at a scale on drone and counter-drone technology that has no historical precedent. The Army’s small cUAS procurement is nearly doubling year over year. None of that guarantees Space-Eyes wins a meaningful share of it.

The investment case becomes genuinely compelling if even a portion of the $35 million in pending contract negotiations converts into signed awards before the shareholder vote. At that point, the revenue multiple compresses, the SPAC redemption risk shrinks, and the sensor-agnostic software platform starts to look like the Palantir comparison the company aspires to rather than aspirational benchmarking.

Until then — watch the contract pipeline. That is the only number that matters between now and Q4.

For informational and educational purposes only. Not investment advice. Trading involves risk, including loss of principal.